ANXA6 and metastatic neoplasm: Since the expression levels of AnxA6 increased with disease progression, we next evaluated whether AnxA6 expression levels detected by IHC differed between TNBC (n = 15) and non-TNBC (n = 116) malignant/metastatic tumors.